Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Sperzel Insider Profile
4 Followers
John Sperzel, Director at diaDexus, holds ― shares in diaDexus (Ticker: DDXSQ), holds 400.00 shares in T2 Biosystems (Ticker: TTOO), holds 473.45K shares in Chembio Diagnostics (Ticker: CEMI). Most recently, John Sperzel ― shares of diaDexus on ― for an estimated value of ―.
John Sperzel diaDexus (DDXSQ)Director
diaDexus (DDXSQ)
Director
Not Ranked
John Sperzel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
, Director
Roles that John Sperzel holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Sperzel
John Sperzel's Trading History
diaDexus
―
―
―
―
T2 Biosystems
Feb 27, 2024
, Director
Uninformative Buy
―
$1.14K
Chembio Diagnostics
Jun 25, 2019
―
Uninformative Buy
―
$215.42K
List of latest transactions for each holding click on a transaction to see John Sperzel's performance on stock
You May Also Like
John Sperzel insider profile FAQ
What is the percentage of profitable transactions made by John Sperzel?
The percentage of profitable transactions made by John Sperzel is ―.
What is the average return per transaction made by John Sperzel?
The average return per transaction made by John Sperzel is ―.
What stocks does John Sperzel hold?
John Sperzel holds: DDXSQ, TTOO, CEMI stocks.
What was John Sperzel’s latest transaction?
John Sperzel latest transaction was an Uninformative Buy of ―.
What was John Sperzel's most profitable transaction?
John Sperzel’s most profitable transaction was an Informative Buy of TTOO stock on April 11, 2022. The return on the trade was -98.30%.
What is John Sperzel's role in diaDexus?
John Sperzel's role in diaDexus is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.